DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Arimidex (Anastrozole) - Current Clinical Trials

 
 



Arimidex Related Clinical Trials

Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer [Completed]

Gynecomastia Extension Study [Completed]

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer [Completed]

Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer [Active, not recruiting]

Open Label Arimidex in Gynecomastia [Completed]

Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer [Recruiting]

Treatment of Sexual Dysfunction in Men With Epilepsy With Testosterone and Either Arimidex or Placebo [Completed]

A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer. [Recruiting]

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing) [Not yet recruiting]

ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years [Active, not recruiting]

MK2206 and Anastrozole, Letrozole, Exemestane, or Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer [Recruiting]

Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer [Active, not recruiting]

Entinostat and Anastrozole in Treating Postmenopausal Women With Triple-Negative Breast Cancer That Can Be Removed by Surgery [Recruiting]

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy [Active, not recruiting]

Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer [Completed]

Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women. [Active, not recruiting]

A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer [Active, not recruiting]

A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZDO530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer [Recruiting]

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer [Recruiting]

Trial Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor (ER) and/or Progesterone Receptor (PgR) Metastatic Breast Cancer [Completed]

Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys [Active, not recruiting]

MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer [Not yet recruiting]

Anastrozole in Patients With Pulmonary Arterial Hypertension [Recruiting]

Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer [Recruiting]

Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer. [Recruiting]

Pazopanib Hydrochloride and Anastrozole Before Surgery in Treating Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer [Recruiting]

PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer [Not yet recruiting]

Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction [Active, not recruiting]

Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women [Recruiting]

An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment [Recruiting]

Second Line Breast Cancer Trial [Completed]

Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study [Completed]

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid [Active, not recruiting]

Arimidex in McCune Albright Syndrome [Completed]

PROACT - Pre-Operative Arimidex Compared To Tamoxifen [Completed]

Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer [Recruiting]

Fulvestrant With or Without Anastrozole or Exemestane Alone in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer [Recruiting]

Non-Interventional Study to Evaluate Arimidex in Postmenopausal Women With Advanced Breast Cancer [Completed]

Faslodex Advanced Breast Cancer Local Chinese Study [Completed]

Anti-Tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer [Recruiting]

Liver Safety Under Upfront Arimidex vs Tamoxifen [Recruiting]

Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women [Active, not recruiting]

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment [Recruiting]

Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer [Recruiting]

Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer [Active, not recruiting]

Survey Conducted Among Early Breast Cancer Patients Treated With Arimidex for Evaluation of Treatment Adherence [Not yet recruiting]

Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence [Recruiting]

Anastrozole With or Without Lonafarnib in Treating Postmenopausal Women With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer [Completed]

Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (Study P03480AM5) [Recruiting]

Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis] [Active, not recruiting]

Arimidex Therapy Compliance Electronic Monitoring System [Recruiting]

Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer [Recruiting]

Aromatase Inhibitor in Bone Maturation, Children With Silver Russell or Prader-Willi Syndrome [Recruiting]

Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI) [Recruiting]

Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women With Clinical Stage II and III Estrogen Receptor Positive Breast Cancer [Recruiting]

Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature [Recruiting]

Hormone Blockade in Combination With Targeted Agents [Recruiting]

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot) [Recruiting]

Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer [Recruiting]

Randomized Phase II Trial of Anastrozole Plus Metronomic Tegafur-uracil as Neo-adjuvant Therapy in Postmenopausal Breast Cancer [Recruiting]

ITT4 Intratesticular Hormonal Milieu in Man (ITT4) [Recruiting]

Arthralgia During Anastrozole Therapy for Breast Cancer [Recruiting]

ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-Positive Breast Cancer With Good to Moderate Differentiation. [Completed]

A Study to Evaluate the Efficacy and Safety of Herceptin (Trastuzumab) in Combination With an Aromatase Inhibitor in Patients With Metastatic Breast Cancer [Active, not recruiting]

Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery [Recruiting]

Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer [Recruiting]

Anastrozole and ZD 1839 in Treating Postmenopausal Women With Metastatic Breast Cancer [Completed]

Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ [Recruiting]

Anastrozole or Fulvestrant in Treating Postmenopausal Women With Stage II or Stage III Breast Cancer That Can Be Removed By Surgery [Recruiting]

Aromasin vs Arimidex Study As Initial Hormonal Therapy in Postmenopausal Women With Advanced/Recurrent Breast Cancer [Recruiting]

Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer [Completed]

Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer [Recruiting]

Study on Pre-Menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex [Completed]

Anastrozole and Gefitinib Compared With Fulvestrant and Gefitinib in Treating Postmenopausal Women With Recurrent or Metastatic Breast Cancer [Active, not recruiting]

Exemestane or Anastrozole in Treating Postmenopausal Women With Hormone Receptor-Positive Primary Breast Cancer [Active, not recruiting]

Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer [Recruiting]

Secondary Adjuvant Long Term Study With Arimidex [Recruiting]

Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer [Recruiting]

Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Ductal Carcinoma in Situ or Stage I, Stage II, or Stage III Breast Cancer [Active, not recruiting]

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer [Recruiting]

Simvastatin and Anastrozole in Treating Postmenopausal Women With Invasive Breast Cancer, Ductal Carcinoma In Situ, or a High Risk of Breast Cancer [Recruiting]

Aromatase Inhibitors in the Treatment of Male Infertility [Recruiting]

Breast Cancer Tumor Care Observational Programme [Recruiting]

3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer [Completed]

Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients [Active, not recruiting]

Patient's Anastrozole Compliance to Therapy Programme [Recruiting]

Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis [Completed]

Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer [Recruiting]

Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment [Recruiting]

Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer [Recruiting]

High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status [Recruiting]

Partial Double-Blind, Placebo-Controlled Study to Assess the Effect of Anastrozole on the Endometrium in Healthy Volunteers [Recruiting]

Arimidex Observational: Reason for and Effect of Change From Tamoxifen [No longer recruiting]

Arimidex Neoadjuvant in Operable Breast Cancer in Post-Menopausal Women [Recruiting]

Anastrozole Administration in Elderly Hypogonadal Men [No longer recruiting]

Phase II Anastrozole and ZD6474 in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer [Recruiting]

Anastrozole and Letrozole [Recruiting]

Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure [Recruiting]

Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole [Recruiting]

Flaxseed and/or Anastrozole in Treating Postmenopausal Women Undergoing Surgery for Newly Diagnosed Stage I or Stage II Breast Cancer [Recruiting]

Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014